Published in Ann Rheum Dis on September 01, 1986
Second line (disease modifying) treatment in rheumatoid arthritis: which drug for which patient? Ann Rheum Dis (1993) 1.08
Have traditional DMARDs had their day? Effectiveness of parenteral gold compared to biologic agents. Clin Rheumatol (2004) 0.90
Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis. Ann Rheum Dis (1992) 0.86
Outcome of second line therapy in rheumatoid arthritis. Ann Rheum Dis (1994) 0.86
A 10 year follow up of parenteral gold therapy in patients with rheumatoid arthritis. Ann Rheum Dis (1996) 0.78
DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association. Ann Rheum Dis (1959) 26.58
The assessment of disease activity in rheumatoid arthritis using a multivariate analysis. Rheumatol Rehabil (1981) 2.88
Does second-line therapy affect the radiological progression of rheumatoid arthritis? Ann Rheum Dis (1984) 1.69
Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum (1983) 1.39
An analysis of worldwide safety experience with auranofin. J Rheumatol (1985) 1.21
Oral gold: a comparison with placebo and with intramuscular sodium aurothiomalate. Clin Rheumatol (1984) 1.03
Radiographic evaluation of erosion in rheumatoid arthritis: double blind study of auranofin vs placebo. J Rheumatol (1984) 0.88
Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest (1999) 7.69
Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science (1987) 5.11
Myalgic encephalomyelitis: International Consensus Criteria. J Intern Med (2011) 4.98
Results of Operations at the Johns Hopkins Hospital for Cancer of the Breast: Performed at the Johns Hopkins Hospital from 1889 to 1931. Ann Surg (1932) 4.54
Sequence-specific interaction of R17 coat protein with its ribonucleic acid binding site. Biochemistry (1983) 4.09
Tumors of the breast related to the oestrin hormone. Am J Cancer (1934) 3.51
Interaction of R17 coat protein with its RNA binding site for translational repression. J Biomol Struct Dyn (1983) 3.20
Gel retardation. Methods Enzymol (1991) 3.11
GYNECOMASTIA, VIRGINAL HYPERTROPHY AND FIBROADENOMAS OF THE BREAST. Ann Surg (1934) 2.83
SUBCUTANEOUS INJURIES OF THE ABDOMEN. Ann Surg (1933) 2.77
Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest (1995) 2.66
Tandem binding in crystals of a trp repressor/operator half-site complex. Nature (1993) 2.65
Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate. Br Med J (Clin Res Ed) (1983) 2.63
Broadly reactive reverse transcriptase polymerase chain reaction for the diagnosis of SRSV-associated gastroenteritis. J Med Virol (1995) 2.53
Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens. Cancer Res (1985) 2.42
Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs. Lancet (1991) 2.37
Toxic amino acids: their action as antimetabolites. Adv Enzymol Relat Areas Mol Biol (1967) 2.35
Interaction of R17 coat protein with synthetic variants of its ribonucleic acid binding site. Biochemistry (1983) 2.30
A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med (1995) 2.29
Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci U S A (1996) 2.20
Sequence of an HLA-DR alpha-chain cDNA clone and intron-exon organization of the corresponding gene. Nature (1982) 2.18
Kinetic and thermodynamic characterization of the R17 coat protein-ribonucleic acid interaction. Biochemistry (1983) 2.07
Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity. Ann Rheum Dis (1993) 2.05
Spatial and temporal variation in abundance of Anopheles (Diptera:Culicidae) in a malaria endemic area in Papua New Guinea. J Med Entomol (1997) 2.04
Parental confidence in measles, mumps and rubella vaccine: evidence from vaccine coverage and attitudinal surveys. Br J Gen Pract (2002) 2.00
Illiteracy in rheumatoid arthritis patients as determined by the Rapid Estimate of Adult Literacy in Medicine (REALM) score. Rheumatology (Oxford) (2002) 2.00
Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease. J Exp Med (1999) 2.00
Norwalk-like viruses: demonstration of genomic diversity by polymerase chain reaction. J Clin Microbiol (1993) 1.96
Photosynthetic and phylogenetic primers for detection of anoxygenic phototrophs in natural environments. Appl Environ Microbiol (2001) 1.93
A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol (1997) 1.92
Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis. Ann Rheum Dis (1997) 1.87
Molecular detection and epidemiology of Sapporo-like viruses. J Clin Microbiol (2000) 1.86
Sequences related to HLA-DR alpha chain on human chromosome 6: restriction enzyme polymorphism detected with DC alpha chain probes. Proc Natl Acad Sci U S A (1983) 1.85
CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science (1996) 1.84
Use of CHROMagar Candida medium for isolation of yeasts from dental samples. J Clin Microbiol (1995) 1.83
Contribution of meniscal extrusion and cartilage loss to joint space narrowing in osteoarthritis. Clin Radiol (1999) 1.82
Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn (2002) 1.74
TUMORS OF PERIPHERAL NERVES. Ann Surg (1930) 1.73
Genetic analysis of NF1: identification of close flanking markers on chromosome 17. Genomics (1987) 1.73
Does second-line therapy affect the radiological progression of rheumatoid arthritis? Ann Rheum Dis (1984) 1.69
GFAP mutations, age at onset, and clinical subtypes in Alexander disease. Neurology (2011) 1.69
Tightly linked markers for the neurofibromatosis type 1 gene. Genomics (1987) 1.68
Distinct epidemiological patterns of Norwalk-like virus infection. J Med Virol (2000) 1.66
Norwalk agent and other small-round structured viruses in the U.K. J Infect (1991) 1.64
Paternal origin of new mutations in von Recklinghausen neurofibromatosis. Nature (1990) 1.64
Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology (Oxford) (2001) 1.63
Translation activates the paused transcription complex and restores transcription of the trp operon leader region. Proc Natl Acad Sci U S A (1985) 1.59
Nonsteroidal peptic damage in rheumatoid patients receiving second-line drugs. Am J Gastroenterol (1991) 1.57
Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years. Br Med J (Clin Res Ed) (1986) 1.55
GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons. Am J Psychiatry (2001) 1.55
Occult neonatal seizures. Epilepsia (1988) 1.55
Molecular findings in symptomatic and pre-symptomatic Alexander disease patients. Neurology (2002) 1.54
Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials. Ann Intern Med (1992) 1.53
Solution structure of the DNA-binding domain and model for the complex of multifunctional hexameric arginine repressor with DNA. Nat Struct Biol (1997) 1.52
Hemodynamics and anatomy of elastase-induced rabbit aneurysm models: similarity to human cerebral aneurysms? AJNR Am J Neuroradiol (2011) 1.51
Which component of sulphasalazine is active in rheumatoid arthritis? Br Med J (Clin Res Ed) (1985) 1.51
A rheumatological dilemma: is it possible to modify the course of rheumatoid arthritis? Can we answer the question? Ann Rheum Dis (1985) 1.50
Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Ann Intern Med (1998) 1.50
Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis. Ann Rheum Dis (1985) 1.49
Performance of the applied biosystems ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for sequence-based analysis of HIV-1 in pediatric plasma samples. J Clin Microbiol (2001) 1.47
Alteration of thiol and superoxide dismutase status in rheumatoid arthritis treated with sulphasalazine. Br J Rheumatol (1987) 1.45
Abdominal and Cardiac Evaluation with Sonography in Shock (ACES): an approach by emergency physicians for the use of ultrasound in patients with undifferentiated hypotension. Emerg Med J (2009) 1.44
Workload and stress in consultant medical microbiologists and virologists: a questionnaire survey. J Clin Pathol (2002) 1.42
PERIPHERAL NERVE INJURIES ASSOCIATED WITH FRACTURES. Ann Surg (1922) 1.42
Antineutrophil cytoplasmic antibody titres in patients with recent infection. Br J Rheumatol (1993) 1.42
The 'natural' history of active rheumatoid arthritis over 3-6 months--an analysis of patients enrolled into trials of potential disease-modifying anti-rheumatic drugs, and treated with placebo. Br J Rheumatol (1993) 1.42
Two highly homologous putative DNA-binding proteins in yeast and E. coli. Trends Biochem Sci (1994) 1.41
A case of orbital myositis associated with rheumatoid arthritis. Ann Rheum Dis (2002) 1.40
Why isolate theatre suites? Lancet (1991) 1.39
Treating osteoporosis: do bisphosphonates really increase the risk of osteonecrosis of the jaw? Ir Med J (2008) 1.39
Recurrent tetanus. Lancet (2004) 1.39
Predictive value of interleukin 1 gene polymorphisms for surgery. Ann Rheum Dis (2000) 1.38
Ordered self-assembly of polypeptide fragments to form nativelike dimeric trp repressor. Science (1992) 1.36
Intimin-specific immune responses prevent bacterial colonization by the attaching-effacing pathogen Citrobacter rodentium. Infect Immun (2001) 1.34
The use of the Internet as a resource for health information among patients attending a rheumatology clinic. Rheumatology (Oxford) (2002) 1.33
Predicting hypoxia in children with acute lower respiratory infection: a study in the highlands of Papua New Guinea. J Trop Pediatr (1995) 1.32
Effect of ipratropium bromide treatment on oxygen saturation and sleep quality in COPD. Chest (1999) 1.31
Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy. Br J Rheumatol (1985) 1.30
Relationship between humoral response to Plasmodium falciparum merozoite surface antigen-2 and malaria morbidity in a highly endemic area of Papua New Guinea. Am J Trop Med Hyg (1994) 1.30
Sulphasalazine: a 'new' antirheumatic drug. Br J Rheumatol (1984) 1.30
Effect of sulphasalazine on the radiological progression of rheumatoid arthritis. Ann Rheum Dis (1987) 1.29
The existence of an optimal range of cytosolic free calcium for insulin-stimulated glucose transport in rat adipocytes. J Biol Chem (1987) 1.29
Genomic diversity of small round structured viruses in the United Kingdom. J Med Virol (1994) 1.29
Cell surface characterization of the human osteoclast: phenotypic relationship to other bone marrow-derived cell types. J Pathol (1984) 1.28
Workshop on schizophrenia. Proc Natl Acad Sci U S A (1997) 1.28
Viral measurement by polymerase chain reaction-based assays in human immunodeficiency virus-infected infants. J Pediatr (1995) 1.27
Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies. Arthritis Rheum (2008) 1.24
A noncovalent peptide complex as a model for an early folding intermediate of cytochrome c. Biochemistry (1993) 1.24
Gonadal steroids: effects on excitability of hippocampal pyramidal cells. Science (1980) 1.23
Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis. J Clin Invest (1999) 1.23
Sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA) gene silencing and remodeling of the Ca2+ signaling mechanism in cardiac myocytes. Proc Natl Acad Sci U S A (2004) 1.21
trp repressor interactions with the trp aroH and trpR operators. Comparison of repressor binding in vitro and repression in vivo. J Mol Biol (1988) 1.20
Detailed characterization of the cooperative mechanism of Ca(2+) binding and catalytic activation in the Ca(2+) transport (SERCA) ATPase. Biochemistry (2000) 1.20
Isochromosome 12p mosaicism (Pallister mosaic aneuploidy or Pallister-Killian syndrome): report of 11 cases. Am J Med Genet (1987) 1.20
A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases. Ann Rheum Dis (1991) 1.20
Modulation of calcium binding in sarcoplasmic reticulum adenosinetriphosphatase. Biochemistry (1981) 1.19
Clinical and laboratory studies of levamisole in patients with rheumatoid arthritis. Q J Med (1978) 1.19
Hormone secretagogues increase cytosolic calcium by increasing cAMP in corticotropin-secreting cells. Proc Natl Acad Sci U S A (1985) 1.19
Babesiosis in man: a case from Scotland. Br Med J (1979) 1.19